Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

White House Eyes Up to 250% Drug Tariffs, Navarro Says - AstraZeneca (NASDAQ:AZN)

Summary by Benzinga
White House trade adviser Peter Navarro discusses tariffs on pharma imports under a "Section 232" trade investigation.

2 Articles

CNBCCNBC
Center

White House Sr. Trade Counselor Peter Navarro: Global supply chains are fragile

Peter Navarro, White House senior counselor for trade and manufacturing, joins 'Money Movers' to discuss the president signing an executive order aimed at boosting U.S. pharma supply chain.

·United States
Read Full Article
BenzingaBenzinga
Center

White House Eyes Up to 250% Drug Tariffs, Navarro Says - AstraZeneca (NASDAQ:AZN)

White House trade adviser Peter Navarro discusses tariffs on pharma imports under a "Section 232" trade investigation.

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Thursday, August 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Peter Navarro icon

Peter Navarro

Trade icon

Trade

White House icon

White House

Tariffs icon

Tariffs

United States icon

United States

News
For You
SearchBlindspotLocal